6-8 December 2016

London

Adopt New Preclinical Strategies to Reduce Failure Rates

The 5th Annual Tumour Models London Summit is back to share the best preclinical research that demonstrates predictability and effectively recapitulates human biology.

Join pharma, biotech and academic institutions as they reveal unpublished discoveries and preclinical case studies that use in vivo, ex vivo and in vitro models. Learn from the successes and failures of humanized mouse models to accurately predict human responses and future proof clinical success.

"I’m most looking forward to see emerging data on the use of innovative mouse tumour models to profile novel cancer immuno-therapies." - Markus Reschke, Boehringer Ingelheim

LinkedIn Youtube Replace